期刊文献+

λpL/pR-cI857温控系统的改造及其对大肠杆菌菌蜕制备的影响 被引量:4

Mutation of λpL/pR-cI857 system for production of bacterial ghost in Escherichia coli
原文传递
导出
摘要 菌蜕是革兰氏阴性菌在噬菌体Phix174的溶菌基因E的作用下形成的细菌空壳,通常由λpL/pR-cI857温控系统通过调控E基因的表达制备。通过重叠PCR技术,将λpL/pR-cI857温控系统中λpR启动子的第2个操纵基因(OR2)的第9位碱基由T突变为C(T→C)。溶菌试验结果表明,突变后的λpL/pR-cI857系统在37℃时仍能稳定抑制基因E的表达,对大肠杆菌的溶菌率为99.9%。通过对λpR启动子的改造,扩大了λpL/pR-cI857温控系统的温度调控范围,为菌蜕疫苗的研制提供了参考。 Bacterial ghost is intact envelope of Gram-negative bacteria, which is produced by the function of the lysis gene E from bacteriophage PhiX174. The expression of the lysis gene E is usually controlled by the thermosensitive λpL/pR-cI857 promoter. In this study, we described a mutation (T→C) at the ninth nucleotide of the OR2 in the kpR promoter of theλpL/pR-cI857 system by overlap PCR. The bacteriolytic assay showed that the mutation in the λpL/pR-cI857 system enhanced the temperature of repressing the expression of gene E up to 37 ℃. The lysis efficiency of altered λpR promoter in Escherichia coli DHS5a and avian pathogenic E. coli DE17 was up to 99.9%. The expanded range of temperature will benefit for the production of bacterial ghost.
出处 《生物工程学报》 CAS CSCD 北大核心 2012年第12期1423-1430,共8页 Chinese Journal of Biotechnology
基金 国家自然科学基金(Nos.31001078 31072161 30871851)资助~~
关键词 大肠杆菌 菌蜕 重叠PCR 突变 Escherichia coli, bacterial ghosts, overlap PCR, mutation
  • 相关文献

参考文献24

  • 1Witte A, Lubitz W. Biochemical characterization of PhiX174 protein E-mediated lysis of Escherichia I coli. Eur J Biochem, 1989, 180(2): 393-398.
  • 2Witte A, Blasi U, Halfmann G, et al. Phi X174 1 protein E-mediated lysis of Escherichia coli. ; Biochimie, 1990,72(2/3): 191-200.
  • 3Lubitz W. Bacterial ghosts as carrier and targeting systems. Expert Opin Bioi Ther, 2001, 1(5): 765-771.
  • 4Kudela P, Koller VJ, Lubitza W. Bacterial ghosts (BGs)-Advanced antigen and drug delivery system. Vaccine, 2010, 28(36): 5760-5767.
  • 5Mayrhofer P, Tabrizi CA, Walcher P, et al. Immobilization of plasmid DNA in bacterial ghosts. J Control Release, 2005, 102(3): 25-35.
  • 6Mader HJ, Szostak MP, Hensel A, et al. Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines. Vaccine, 1997, 15(2): 195-202.
  • 7Eko FO, Lubitz W, McMillan L, et al. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis. Vaccine, 2003, 21(15): 1694-1703.
  • 8Mayr UB, Walcher P, Azimpour C, et al. Bacterial ghosts as antigen delivery vehicles. Adv Drug Deliv Rev, 2005, 57(9): 1381-1391.
  • 9Pavol K, Susanne P, Ulrike BM, et al. Effective gene transfer to melanoma cells using bacterial ghosts. Cancer Lett, 2008, 262: 54-63.
  • 10Tabrizi CA, Walcher P, Mayr UB, et al. Bacterial ghosts-biological particles as delivery systems for antigens, nucleic acids and drugs. Curr Opin Biotechnol, 2004, 15(6): 530-537.

二级参考文献6

  • 1胡青海,刘晓文,苗晋锋,赵东伟,张知良,丁铲.当前我国鸭病de流行动态与防制对策[J].中国禽业导刊,2001,18(23):18-18. 被引量:4
  • 2Zhao S,Muarer J J,Htlbert S,et al.Antimicrobialsusceptibility and molecular characterization of avianpathogenicEscherichia coliisolates. Veterinary Microbiology . 2005
  • 3Dozois CM,Fairbrother JM,Harel J,et al.Pap-and pil-related DNA sequences and other virulence determinants associated with Escherichia coli isolated from septicemic chickens and turkeys. Infection and Immunity . 1992
  • 4Christa Ewers,Traute JanBen,Sabine KieBling,et al.Molecular epidemiology of avian pathogenic Escherichia coli (APEC) isolated from colisepticemia in poultry. Veterinary Microbiology . 2004
  • 5Dho-Moulin M,Fairbrother J M.Avian pathogenic Escherichia coli(APEC). Veterinary Research . 1999
  • 6Cloud S S,Rosenberger J K,Fries P A,et al.In Vitro and Vivo Characterization of Avian Escherichta coil.I. Serotypes,Metabolic Activity and Antiiotic Sensitivity. Avian Diseases . 1985

共引文献41

同被引文献37

  • 1龚建森,徐敬潇,付立霞,韩先干,张笛,董永毅,徐步.利用温控双表达载体制备印第安纳沙门菌菌蜕[J].中国预防兽医学报,2021,43(3):246-251. 被引量:1
  • 2张大军,冯博,皇甫永穆.双Tac启动子的构建及其对人白细胞介素2在大肠杆菌中表达的影响[J].同济医科大学学报,1993,22(4):226-229. 被引量:2
  • 3张绪梅,郭长江,刘云,杨继军,韦京豫,徐琪寿.大肠杆菌trpBA基因的克隆表达[J].生物技术通讯,2006,17(1):12-14. 被引量:5
  • 4Walcher P, Mayr U B, Azimpour-Tabrizi C, et al. An tigen discovery and delivery o{ subunit vaccines by nonliving bacterial ghost vectors[J]. Expert Rev Vac- cines,2004,3(6) :681-691.
  • 5Khan A S, Mujer C V, Alefantis T G, et al. Pro teomics and bioinformatics strategies to design coun- termeasures against infectious threat agents [J ]. J Chem Infect Model, 2006,46 (1) .. 111-115.
  • 6Eko F O, Talin B A, Lubitz W. Development of a Chlamydia trachomatis bacterial ghost vaccine tofight human blindness[J]. Hum Vaccin, 2008,4 (3) : 176-183.
  • 7Wen J, Yang Y, Zhao G, et al. Salmonella typhi Ty21a bacterial ghost vector augments HIV 1 gp140 DNA vaccine-induced peripheral and mueosal antibody responses via TLR4 pathway[J]. Vaccine, 2012, 30 (39) : 5733-5739.
  • 8Cai K,Zhang Y, Yang B, et al. Yersinia enterocolitica ghost with msbB mutation provides protection and re- duces proinflammatory cytokines in mice[J]. Vaccine, 2013,31(2) :334 340.
  • 9Fu L, Lu C. A novel dual vector coexpressing PhiX174 lysis E gene and staphylococcal nuclease A gene on the basis of larnbda promoter pR and pL, respectively [J]. Mol Biotechnol,2013,54(2) :436-444.
  • 10Langemann T, Koller V J, Muhammad A, et al. The bacterial ghost platform system:production and appli- cations[J]. Bioeng Bugs, 2010,1 (5) : 326-336.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部